Research: Retroperitoneal Lymphadenectomy for High Risk, Nonmetastatic Renal Cell Carcinoma
4 Jan, 2018 | 16:59h | UTCRetroperitoneal Lymphadenectomy for High Risk, Nonmetastatic Renal Cell Carcinoma: An Analysis of the ASSURE (ECOG-ACRIN 2805) Adjuvant Trial – Journal of Urology (free for a period)
Commentary: Lymphadenectomy in Renal Cell Carcinoma: No Benefit? – Medscape (free registration required)